Lankenau Institute for Medical Research

Lankenau Institute for Medical Research
LIMR

About the Lankenau Institute for Medical Research

At Lankenau Institute for Medical Research (LIMR) we study and seek remedies for cancer as well as cardiovascular, autoimmune, gastrointestinal and other diseases. Our research is at the leading edge of today’s immunotherapy revolution in health care. Our guiding principle: In medicine, hope springs from research.

Learn more about LIMR

Primary research programs

At the forefront of cancer research
Cancer researcher using microscope
Developing new drugs and devices for cardiovascular disease
Anatomical heart illustration
Diving deeper into clinical issues
LIMR researchers using dropper

Support Lankenau Institute for Medical Research

Your support of LIMR's research can drive groundbreaking advances in healthcare. Our renowned scientists are making strides in cancer, autoimmune disorders, regenerative medicine and beyond with the goal of translating their discoveries into real-world patient care. Be a catalyst for change and help shape the future of medicine.

Give now

Featured research

Results from an early trial by a company with ties to the Lankenau Institute for Medical Research offer hope that a potent form of attack against metastatic prostate cancer is on the horizon. Charles J. Link, MD; Jonathan Lewis, MD; and George Prendergast, PhD, President and CEO of LIMR, are spearheading the effort.

Learn more in Catalyst
Stethoscope, pill packs, syringe and bottles on white surface

Acapreneurial™

The Lankenau Institute for Medical Research's signature ACAPRENEURIAL™ model focuses on invention, intellectual property and new company development, with a secondary goal of pursuing new academic knowledge.

Learn more about acapreneurialism
ACAPRENEURIAL logo